1. Hong Kong Stocks

  2. •

    Health technology

  3. •

    Medical specialties
Sun Hing Vision Group Holdings Limited

Sun Hing Vision Group Holdings Limited

HHKEX:125
0.29
HKD
+0.01
(+1.79%)
90.66MMarket Cap
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
4.48
4.62
4.1
4.06
3.81
4.66
3.47
2.67
3.34
2.68
2.67
3.15
3.39
- -
Basic EPS, GAAP
0.17
0.25
0.21
0.27
0.24
0.27
-0.63
0.04
0.03
-0.12
-0.11
-0.12
-0.17
- -
Free Cash Flow per Basic Share
0.09
0.34
0.17
0.48
0.1
0.29
-0.01
0.07
0.11
0.09
-0.14
-0.29
-0.18
- -
Dividend per Share
0.17
0.21
0.24
0.23
0.25
0.18
0.12
- -
0.03
0.03
0.03
0.02
- -
- -
Book Value per Share
3.51
3.56
3.52
3.55
3.57
3.63
2.87
2.93
2.97
2.75
2.55
2.4
2.27
2.27
Tangible Book Value per Share
3.5
3.55
3.51
3.54
3.35
3.41
2.68
2.74
2.79
2.6
2.41
2.26
2.15
2.15
Basic Weighted Avg Shares
263
263
263
263
263
263
263
263
263
263
263
263
263
263
Sales/Revenue/Turnover
1,177
1,214
1,078
1,067
1,002
1,224
913
702
877
705
702
828
891
- -
Operating Margin (%)
4.4
6.49
6.18
8.71
6.8
5.79
-1.8
-0.88
0.59
-3.49
-8.43
-6.44
-6.06
- -
Depreciation Expense
52
52
49
51
50
56
75
27
30
30
25
25
25
- -
Net Income, GAAP
44
67
55
71
64
72
-166
10
9
-31
-28
-32
-46
- -
Effective Tax Rate (%)
7.8
19.51
13.96
18.62
13.97
14.43
- -
- -
6.44
- -
- -
- -
- -
- -
Profit Margin (%)
3.76
5.52
5.14
6.64
6.39
5.89
-18.18
1.37
1.04
-4.33
-4.04
-3.89
-5.15
- -
Working Capital
628
657
626
650
573
478
405
404
413
400
342
298
264
264
LT Debt
- -
- -
- -
- -
- -
- -
19
15
11
5
9
7
23
23
Total Equity
924
937
925
932
938
954
756
771
781
722
670
630
598
598
Return on Invested Capital (%)
4.74
7.13
5.79
7.52
6.48
6.17
- -
- -
0.98
- -
- -
- -
- -
- -
Return on Capital (%)
4.75
7.23
6.05
7.67
6.83
7.48
- -
- -
1.33
- -
- -
- -
- -
- -
Return on Common Equity (%)
4.75
7.21
5.96
7.64
6.85
7.63
-19.42
1.26
1.17
-4.06
-4.07
-4.96
-7.48
- -

Capital Structure

HKD

•

in mil. unless spec.
Mar'25
Sep'26
Mar'26
ST Debt
43
50
39
LT Borrowings
- -
- -
21
LT Finance Leases
7
5
2
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
263
263
263
Market Capitalization
100
101
91

Working Capital

HKD

•

in mil. unless spec.
Mar'25
Sep'26
Mar'26
Total Current Assets
548
559
576
Cash, Cash Equivalents & STI
185
120
148
Accounts Receivable, Net
202
264
241
Inventories
127
148
148
Total Current Liabilities
250
293
312
Payables & Accruals
- -
- -
- -
ST Debt
43
50
39
Deferred Revenue
- -
- -
- -

Growth Rates

HKD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-4.02%
-4.9%
-5.11%
Free Cash Flow
-64.87%
-30.45%
-38.42%
Net Income, GAAP
-79.76%
-78.53%
42.35%
Sales/Revenue/Turnover
-0.3%
6.1%
7.55%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

HKD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
702
2025
- -
- -
828
2026
- -
- -
891

Semi-annual Earnings Per Share

HKD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
-0.11
2025
- -
- -
-0.12
2026
- -
- -
-0.17

Semi-annual Dividends Per Share

HKD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
0.03
2025
- -
- -
0.02
2026
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Ngai Yung Ku
Full Time Employees
3,000
Sector
Health technology
Industry
Medical specialties
Address
EGL Tower Hong Kong HK Hong Kong
IPO Date
May 25, 1999
Website
sunhingoptical.com
Similar Companies
Intuitive Surgical, Inc. (NASDAQ:ISRG)
Boston Scientific Corporation (NYSE:BSX)
Thermo Fisher Scientific Inc (NYSE:TMO)
Illumina, Inc. (NASDAQ:ILMN)
Abbott Laboratories (NYSE:ABT)
GRAIL, Inc. (NASDAQ:GRAL)
Business
Sun Hing Vision Group Holdings Limited engages in the manufacturing and trading of eyewear products, including optical frames, sunglasses, and related accessories. The company operates primarily through two business segments: Eyewear Products, which involves original design manufacturing (ODM) of eyewear, and Trademarks, focused on granting licenses of trademarks. Its product portfolio features notable brands such as New Balance, agnès b., Levi’s, Jill Stuart, Bally, Celine Dion, and Missoni, alongside its proprietary house brand Public+. The company is active in markets including Hong Kong, Macau, Mainland China, Japan, Italy, the United States, and other international regions. Founded in 1999 and headquartered in Kwun Tong, Hong Kong, Sun Hing Vision also engages in contact lens trading and property holding activities. Recent major developments include a reported turnover increase to HKD 421 million for the half-year ended September 30, 2025, driven by growth in its ODM business, particularly in Europe and Asia, despite challenges from US tariff measures affecting global supply chains. The company has completed the construction of a new production plant in Vietnam to diversify its manufacturing base and increase capacity. It continues to focus on operational efficiency through workforce restructuring and enhanced marketing efforts to expand its product range with more diverse design and pricing options. The group also reported a net loss increase, reflecting a competitive industry environment and restructuring costs. The company maintains strong liquidity and financial resources to support its ongoing growth and adapts to the volatile geopolitical and macroeconomic landscape. Sun Hing Vision’s strategic focus emphasizes strengthening product development, brand management, and geographic diversification to mitigate supply chain risks and capture new market opportunities in the eyewear industry. Its subsidiaries include entities such as 101 (Hong Kong) Limited and New Prosperity Optical Manufactory Limited, supporting its manufacturing and distribution capabilities. The group’s sustained efforts in ODM and licensing, combined with enhanced operational bases outside China, position it to navigate the evolving global trade and economic conditions effectively.